{"id":"bolus-surfactant","safety":{"commonSideEffects":[{"rate":null,"effect":"Transient oxygen desaturation"},{"rate":null,"effect":"Bradycardia"},{"rate":null,"effect":"Pulmonary hemorrhage"},{"rate":null,"effect":"Intraventricular hemorrhage"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Surfactant is a naturally occurring mixture of lipids and proteins that lines the alveoli and reduces surface tension, preventing alveolar collapse during respiration. Bolus surfactant administration directly replaces deficient endogenous surfactant in premature infants whose lungs lack sufficient surfactant production, thereby improving lung compliance and oxygenation.","oneSentence":"Bolus surfactant reduces surface tension in the lungs to improve gas exchange and respiratory function in neonates with respiratory distress syndrome.","_ai_confidence":"medium"},"_scrapedAt":"2026-03-28T00:28:44.936Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Respiratory distress syndrome in premature neonates"},{"name":"Meconium aspiration syndrome"}]},"trialDetails":[{"nctId":"NCT03969992","phase":"PHASE2","title":"A Dose-Ranging Study to Determine the Efficacy, Safety and Tolerability of AeroFact","status":"COMPLETED","sponsor":"Aerogen Pharma Limited","startDate":"2020-03-04","conditions":"Respiratory Distress Syndrome in Premature Infant","enrollment":261},{"nctId":"NCT06090981","phase":"NA","title":"Early Bolus Surfactant Replacement Therapy Versus Standard Care in Term Neonates With Meconium Aspiration Syndrome","status":"COMPLETED","sponsor":"Lady Hardinge Medical College","startDate":"2022-03-12","conditions":"Meconium Aspiration Syndrome, Surfactant Dysfunction","enrollment":60},{"nctId":"NCT04502433","phase":"PHASE2","title":"Poractant Alfa (Curosurf®)) -- Effect in Adult Patients Diagnosed With 2019 Novel Coronavirus (SARS-COV-19; (Covid-19)) Acute Respiratory Distress Syndrome (ARDS)","status":"TERMINATED","sponsor":"Chiesi Farmaceutici S.p.A.","startDate":"2021-01-06","conditions":"Acute Respiratory Distress Syndrome","enrollment":22},{"nctId":"NCT03718507","phase":"PHASE1","title":"Study on the Effects of Different Premedication for LISA on Stress and Cerebral Tissue Oxygenation in Preterm Infants","status":"WITHDRAWN","sponsor":"ASST Fatebenefratelli Sacco","startDate":"2019-05-20","conditions":"Respiratory Distress Syndrome, Surfactant Deficiency Syndrome Neonatal, Near Infrared Spectroscopy","enrollment":""},{"nctId":"NCT00215553","phase":"PHASE2","title":"KL₄Surfactant Treatment in Patients With ARDS","status":"TERMINATED","sponsor":"Windtree Therapeutics","startDate":"2001-05","conditions":"Acute Respiratory Distress Syndrome","enrollment":124},{"nctId":"NCT03371680","phase":"NA","title":"Kinetics of Surfactant Proteins, Phosphatidylcholine and Body Water in Intensive Care Unit (ICU)","status":"COMPLETED","sponsor":"University of Padova","startDate":"2010-10","conditions":"ARDS, Sepsis Syndrome","enrollment":21},{"nctId":"NCT02041546","phase":"PHASE4","title":"Lung Lavage With Dilute Poractant Alfa for Meconium Aspiration Syndrome","status":"COMPLETED","sponsor":"Zekai Tahir Burak Women's Health Research and Education Hospital","startDate":"2013-09","conditions":"Meconium Aspiration Syndrome","enrollment":30},{"nctId":"NCT02825953","phase":"NA","title":"Does The Surfactant Administration by Aerosolization Effective?","status":"UNKNOWN","sponsor":"nihat demir","startDate":"2016-01","conditions":"Respiratory Distress Syndrome, Surfactant Administration by Aerosolization","enrollment":75},{"nctId":"NCT01848262","phase":"NA","title":"ECALMIST Versus InSurE in Preterm Infant < 32 Weeks,Multicenter, Multinational RCT","status":"UNKNOWN","sponsor":"University of Manitoba","startDate":"2013-06","conditions":"Respiratory Distress Syndrome","enrollment":100},{"nctId":"NCT01923844","phase":"PHASE4","title":"Effects of Bolus Surfactant Therapy on Peripheral Perfusion Index and Tissue Carbon Monoxide","status":"COMPLETED","sponsor":"Ege University","startDate":"2012-03","conditions":"Respiratory Distress Syndrome","enrollment":48},{"nctId":"NCT00004500","phase":"PHASE3","title":"Phase III Randomized Study of Lucinactant in Full Term Newborn Infants With Meconium Aspiration Syndrome","status":"TERMINATED","sponsor":"Windtree Therapeutics","startDate":"2000-03","conditions":"Meconium Aspiration","enrollment":69},{"nctId":"NCT01294852","phase":"NA","title":"Comparison of Two Strategies for Surfactant Prophylaxis in Premature Infants","status":"UNKNOWN","sponsor":"Ankara University","startDate":"2010-01","conditions":"Premature Birth, Premature Lungs","enrollment":100},{"nctId":"NCT00797160","phase":"PHASE4","title":"Propofol Versus Midazolam as Premedication for Preterm Neonates With Respiratory Distress Syndrome (RDS)","status":"UNKNOWN","sponsor":"Federal University of Minas Gerais","startDate":"2008-08","conditions":"Respiratory Distress Syndrome","enrollment":20},{"nctId":"NCT00312507","phase":"PHASE3","title":"Surfactant Lavage vs. Bolus Surfactant in Neonates With Meconium Aspiration","status":"UNKNOWN","sponsor":"The Hospital for Sick Children","startDate":"2006-04","conditions":"Meconium Aspiration Syndrome","enrollment":20}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":21,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["Poractant alfa"],"phase":"marketed","status":"active","brandName":"Bolus surfactant","genericName":"Bolus surfactant","companyName":"Zekai Tahir Burak Women's Health Research and Education Hospital","companyId":"zekai-tahir-burak-women-s-health-research-and-education-hospital","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Bolus surfactant is a type of surfactant agent used to treat conditions such as Meconium Aspiration Syndrome, Premature Birth, Premature Lungs, Respiratory Distress Syndrome, and Surfactant Deficiency Syndrome Neonatal. It is administered by bolus and is classified as a surfactant agent, with synonyms including Lucinactant.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}